| 1 |
32930615 | Development of graphene based nanocomposites towards medical and biological applications. | 2020 Dec |
1 |
| 2 |
30663574 | Synthesis of Dual Target CPT-Ala-Nor Conjugates and Their Biological Activity Evaluation. | 2019 |
1 |
| 3 |
30138703 | Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells. | 2018 Oct 25 |
1 |
| 4 |
28131940 | Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles. | 2017 Mar 15 |
4 |
| 5 |
27008798 | INTERACTION OF CAMPTOTHECIN WITH HUMAN SERUM ALBUMIN DETERMINED BY FLUORESCENCE ANISOTROPY SPECTROSCOPY. | 2016 Jan-Feb |
2 |
| 6 |
27869268 | Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation. | 2016 Dec 1 |
2 |
| 7 |
27877240 | ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light Source. | 2016 |
2 |
| 8 |
27934922 | Extreme Activity of Drug Nanocrystals Coated with A Layer of Non-Covalent Polymers from Self-Assembled Boric Acid. | 2016 Dec 9 |
1 |
| 9 |
25798457 | Non-invasive, real-time reporting drug release in vitro and in vivo. | 2015 Apr 25 |
1 |
| 10 |
26455329 | Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. | 2015 Nov 14 |
2 |
| 11 |
25247114 | PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system. | 2014 |
2 |
| 12 |
23750546 | Synthesis, biological evaluation, and in vivo imaging of the first camptothecin-fluorescein conjugate. | 2013 Jul 17 |
1 |
| 13 |
21756949 | Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. | 2011 Dec 10 |
1 |
| 14 |
19887335 | Insilico analysis of homocamptothecin (hCPT) analogues for anti-tumour activity. | 2009 |
1 |
| 15 |
17048510 | Camptothecin in sterically stabilized phospholipid nano-micelles: a novel solvent pH change solubilization method. | 2006 Sep-Oct |
1 |
| 16 |
15766244 | Activation of camptothecin derivatives by conjugation to triple helix-forming oligonucleotides. | 2005 Mar 22 |
1 |
| 17 |
12502373 | Synthesis and in vivo antitumor activity of poly(l-glutamic acid) conjugates of 20S-camptothecin. | 2003 Jan 2 |
1 |
| 18 |
11894136 | Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cells. | 2002 Apr |
1 |
| 19 |
12088114 | Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells. | 2002 May |
1 |
| 20 |
12237769 | A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin. | 2002 Sep 9 |
2 |
| 21 |
11605011 | The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification. | 2001 Nov |
1 |
| 22 |
11762642 | A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38. | 2001 Feb |
3 |
| 23 |
10841808 | Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins. | 2000 Jun 1 |
2 |
| 24 |
11118036 | Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterations. | 2000 Dec 1 |
1 |
| 25 |
10383158 | Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. | 1999 Jun 15 |
3 |
| 26 |
10569939 | Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks. | 1999 Nov 23 |
1 |
| 27 |
9876111 | Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues. | 1998 Dec 31 |
2 |
| 28 |
7766631 | Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. | 1995 May 30 |
1 |
| 29 |
8070019 | 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials. | 1994 |
1 |
| 30 |
8074481 | Establishment of a CPT-11-resistant human ovarian cancer cell line. | 1994 May-Jun |
1 |
| 31 |
2170010 | Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. | 1990 Nov 1 |
2 |
| 32 |
2174738 | Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines. | 1990 Dec 15 |
3 |